Fructus Ligustri Lucidi in Osteoporosis: A Review of its Pharmacology, Phytochemistry, Pharmacokinetics and Safety [PDF]
Molecules, 2017 Background: Fructus Ligustri Lucidi (FLL) has now attracted increasing attention as an alternative medicine in the prevention and treatment of osteoporosis.
Chenyue Liu +2 more
exaly +7 more sources
Regulation of bone and fat balance by Fructus Ligustri Lucidi in ovariectomized mice [PDF]
Pharmaceutical Biology, 2023 Context Fructus Ligustri Lucidi (FLL), a commonly used herb of traditional Chinese medicine (TCM), is the fruit of Ligustrum lucidum Ait. (Oleaceae).
Xiaoyan Qin +7 more
doaj +4 more sources
Anti-Neuroinflammatory Effects and Mechanism of Action of Fructus ligustri lucidi Extract in BV2 Microglia [PDF]
Plants, 2021 For centuries, Fructus ligustri lucidi (FLL; the fruit of Ligustrum lucidum Aiton or Ligustrum japonicum Thunb.) has been commonly used in traditional Chinese medicine for treating hepatitis and aging-related symptoms and in traditional Korean medicine ...
Yeon Ju Kim +3 more
doaj +5 more sources
Transcriptome and metabolome analysis revealed the dynamic change of bioactive compounds of Fructus Ligustri Lucidi [PDF]
BMC Plant BiologyBackground The Fructus Ligustri Lucidi, the fruit of Ligustrum lucidum, contains a variety of bioactive compounds, such as flavonoids, triterpenoids, and secoiridoids. The proportions of these compounds vary greatly during the different fruit development
Peina Zhou +5 more
doaj +4 more sources
Osteoprotective effects of
Chinese Medicine, 2010 Background Fructus Ligustri Lucidi (FLL) is a commonly used herb for treating bone disorders in Chinese medicine. The present study investigates the anti-osteoporotic activity of FLL aqueous extract in the model of postmenopausal bone loss in aged ...
Fung Kwok +5 more
doaj +5 more sources
Fructus Ligustri Lucidi modulates estrogen receptor expression with no uterotrophic effect in ovariectomized rats [PDF]
BMC Complementary and Alternative Medicine, 2018 Background Accumulating evidence suggests that Fructus Ligustri Lucidi (FLL) plays a beneficial role in preventing the development of osteoporosis. However, the effects of FLL on estrogen receptor (ER) α and ERβ expressions remain unknown.
Yu-qing Tang +11 more
doaj +5 more sources
The advances in research on the pharmacological effects of Fructus Ligustri Lucidi. [PDF]
Biomed Res Int, 2015 Fructus Ligustri Lucidiis a well-known invigorator in Chinese materia medica with hepatoprotective effect, anticancer activity, antioxidant activity, and so on. And oleanolic acids are the major pharmacologically active components inFructus Ligustri Lucidi. So it has great value in medical health, and may be developed to a complementary and alternative
Pang Z +6 more
europepmc +5 more sources
Identification of Critical Biomarkers and Mechanisms of Fructus Ligustri Lucidi on Vitiligo Using Integrated Bioinformatics Analysis. [PDF]
Clin Cosmet Investig Dermatol, 2023 Vitiligo is an autoimmune disease of the skin that targets pigment-producing melanocytes and results in patches of depigmentation that are visible as white spots. Recent research studies have yielded a strong mechanistic understanding of this disease. Fructus Ligustri Lucidi (FLL) has been used for premature graying of hair since ancient China and is ...
Liang TS +7 more
europepmc +4 more sources
Protective Effects of Water Extract of Fructus Ligustri Lucidi against Oxidative Stress-Related Osteoporosis In Vivo and In Vitro [PDF]
Veterinary Sciences, 2021 Fructus Ligustri Lucidi (FLL) is the fruit of Ligustrum lucidum Ait and is a component of many kidney-tonifying traditional Chinese medicine formulae for treating osteoporosis.
Yi Wu +6 more
doaj +2 more sources
Optimization of Formulation Parameters in Preparation of Fructus ligustri lucidi Dropping Pills by Solid Dispersion Using 23 Full Experimental Design [PDF]
Pharmaceuticals, 2022 Oleanolic acid (OA) is an active ingredient of the traditional Chinese medicine (TCM) Fructus ligustri lucidi (FLL). Its clinical use is restricted because it is water-insoluble and has limited dosage forms of administration at present.
Kai-Rong Wu, Wen-Ho Chuo, Yuh-Tyng Huang
doaj +2 more sources